Suppr超能文献

嗜铬细胞瘤患者血浆多巴胺-β-羟化酶活性

Plasma dopamine-beta-hydroxylase activity in phaeochromocytoma.

作者信息

Stone R A, Lilley J J, Golden J

出版信息

Clin Endocrinol (Oxf). 1976 Mar;5(2):181-5. doi: 10.1111/j.1365-2265.1976.tb02830.x.

Abstract

Plasma dopamine-beta-hydroxylase (DbetaH) activity, a marker of catecholamine secretion that occurs via exocytosis, was determined preoperatively in eight patients with phaeochromocytoma. Despite very elevated urinary catecholamine concentrations, mean plasma DbetaH activity was 32-6 +/- 3 u/l and was not significantly different from apparently healthy subjects. Seven days after surgery, one subject exhibited a 60% postoperative decrease of enzyme activity. These results suggest that diffusion across plasma membranes is the predominant mechanism of catecholamine release from phaeochromocytomas. The postoperative change in one patient suggests tumour heterogeneity and that exocytosis may contribute to the process of catecholamine release in some patients.

摘要

血浆多巴胺-β-羟化酶(DβH)活性是通过胞吐作用分泌儿茶酚胺的一个标志物,术前对8例嗜铬细胞瘤患者进行了测定。尽管尿儿茶酚胺浓度非常高,但平均血浆DβH活性为32 - 6±3 U/L,与明显健康的受试者无显著差异。术后7天,1例受试者的酶活性术后下降了60%。这些结果表明,跨质膜扩散是嗜铬细胞瘤释放儿茶酚胺的主要机制。1例患者术后的变化提示肿瘤具有异质性,并且胞吐作用可能在某些患者儿茶酚胺释放过程中起作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验